Literature DB >> 18485616

Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma.

Jodi A Muscal1, Jeremy Y Jones, Arnold C Paulino, Alison A Bertuch, Jack Su, Shiao Y Woo, Donald H Mahoney, Murali Chintagumpala.   

Abstract

PURPOSE: Acute and late changes in magnetic resonance imaging of the pediatric brain have been described after radiotherapy (RT). We report the post-RT neuroimaging changes in the posterior fossa after intensity-modulated RT (IMRT) in children with medulloblastoma and contrast them with those of leptomeningeal disease. METHODS AND MATERIALS: We performed a retrospective review of 53 consecutive children with medulloblastoma who were treated with craniospinal RT followed by IMRT to the posterior fossa and chemotherapy between 1997 and 2006.
RESULTS: After IMRT to the posterior fossa, 8 (15%) of 53 patients developed increased fluid-attenuated inversion-recovery signal changes in the brainstem or cerebellum and patchy, multifocal, nodular contrast enhancement at a median of 6 months. The enhancement superficially resembled leptomeningeal disease. However, the enhancement resolved without intervention at a median of 6 months later. The accompanying fluid-attenuated inversion-recovery signal changes occasionally preceded the enhancement, were often parenchymal in location, and resolved or persisted to a lesser degree. All 8 patients with transient magnetic resonance imaging changes in the posterior fossa were alive at last follow-up. In contrast, leptomeningeal disease occurred in 8 (15%) of our 53 patients at a median of 19.5 months after IMRT completion. Of these 8 patients, 7 demonstrated initial nodular enhancement outside the conformal field, and 7 patients died.
CONCLUSION: Magnetic resonance imaging changes can occur in the posterior fossa of children treated with IMRT for medulloblastoma. In our experience, these transient changes occur at a characteristic time and location after RT, allowing them to be distinguished from leptomeningeal disease.

Entities:  

Mesh:

Year:  2008        PMID: 18485616      PMCID: PMC2953789          DOI: 10.1016/j.ijrobp.2008.03.056

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  23 in total

1.  Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation.

Authors:  W E Reddick; J M Russell; J O Glass; X Xiong; R K Mulhern; J W Langston; T E Merchant; L E Kun; A Gajjar
Journal:  Magn Reson Imaging       Date:  2000-09       Impact factor: 2.546

2.  Neuroimaging-detected late transient treatment-induced lesions in pediatric patients with brain tumors.

Authors:  Kathleen J Helton; Michael Edwards; R Grant Steen; Thomas E Merchant; Mark V Sapp; Frederick A Boop; James Langston
Journal:  J Neurosurg       Date:  2005-03       Impact factor: 5.115

3.  Response of recurrent medulloblastoma to low-dose oral etoposide.

Authors:  D M Ashley; L Meier; T Kerby; F M Zalduondo; H S Friedman; A Gajjar; L Kun; P K Duffner; S Smith; D Longee
Journal:  J Clin Oncol       Date:  1996-06       Impact factor: 44.544

4.  Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.

Authors:  D H Mahoney; J J Shuster; R Nitschke; S J Lauer; C P Steuber; N Winick; B Camitta
Journal:  J Clin Oncol       Date:  1998-05       Impact factor: 44.544

5.  Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.

Authors:  Amar Gajjar; Murali Chintagumpala; David Ashley; Stewart Kellie; Larry E Kun; Thomas E Merchant; Shaio Woo; Greg Wheeler; Valerie Ahern; Matthew J Krasin; Maryam Fouladi; Alberto Broniscer; Robert Krance; Gregory A Hale; Clinton F Stewart; Robert Dauser; Robert A Sanford; Christine Fuller; Ching Lau; James M Boyett; Dana Wallace; Richard J Gilbertson
Journal:  Lancet Oncol       Date:  2006-10       Impact factor: 41.316

6.  Transient white matter changes on MR images in children undergoing chemotherapy for acute lymphocytic leukemia: correlation with neuropsychologic deficiencies.

Authors:  D A Wilson; R Nitschke; M E Bowman; M J Chaffin; C L Sexauer; J R Prince
Journal:  Radiology       Date:  1991-07       Impact factor: 11.105

7.  Pattern of recurrence of medulloblastoma after low-dose craniospinal radiotherapy.

Authors:  W M Wara; Q T Le; P K Sneed; D A Larson; M D Prados; V A Levin; M S Edwards; M D Weil
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-10-15       Impact factor: 7.038

8.  Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine.

Authors:  I B Lefkowitz; R J Packer; K R Siegel; L N Sutton; L Schut; A E Evans
Journal:  Cancer       Date:  1990-02-01       Impact factor: 6.860

9.  High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group.

Authors:  I J Dunkel; J M Boyett; A Yates; M Rosenblum; J H Garvin; B C Bostrom; S Goldman; L S Sender; S L Gardner; H Li; J C Allen; J L Finlay
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

10.  Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse?

Authors:  E Bouffet; F Doz; M C Demaille; P Tron; H Roche; D Plantaz; A Thyss; J L Stephan; O Lejars; E Sariban; M Buclon; J M Zücker; M Brunat-Mentigny; J L Bernard; J C Gentet
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

View more
  5 in total

1.  Imaging changes in very young children with brain tumors treated with proton therapy and chemotherapy.

Authors:  N D Sabin; T E Merchant; J H Harreld; Z Patay; P Klimo; I Qaddoumi; G T Armstrong; K Wright; J Gray; D J Indelicato; A Gajjar
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-19       Impact factor: 3.825

Review 2.  The role of radiotherapy in adult medulloblastoma: long-term single-institution experience and a review of the literature.

Authors:  M Balducci; S Chiesa; D Chieffo; S Manfrida; N Dinapoli; A Fiorentino; F Miccichè; V Frascino; C Anile; V Valentini; B De Bari
Journal:  J Neurooncol       Date:  2011-07-31       Impact factor: 4.130

3.  Incidence and clinical course of radionecrosis in children with brain tumors. A 20-year longitudinal observational study.

Authors:  V Strenger; H Lackner; R Mayer; P Sminia; P Sovinz; M Mokry; A Pilhatsch; M Benesch; W Schwinger; M Seidel; D Sperl; S Schmidt; C Urban
Journal:  Strahlenther Onkol       Date:  2013-08-22       Impact factor: 3.621

4.  Pretreatment Normal WM Magnetization Transfer Ratio Predicts Risk of Radiation Necrosis in Patients with Medulloblastoma.

Authors:  J H Harreld; P Zou; N D Sabin; A Edwards; Y Han; Y Li; O Bieri; R B Khan; A Gajjar; G Robinson; T E Merchant
Journal:  AJNR Am J Neuroradiol       Date:  2022-01-20       Impact factor: 3.825

5.  Added value of diffusion weighted imaging in pediatric central nervous system embryonal tumors surveillance.

Authors:  Giovanni Morana; Cesar Augusto Alves; Domenico Tortora; Mariasavina Severino; Paolo Nozza; Armando Cama; Marcello Ravegnani; Gabriella D'Apolito; Alessandro Raso; Claudia Milanaccio; Claudia da Costa Leite; Maria Luisa Garrè; Andrea Rossi
Journal:  Oncotarget       Date:  2017-07-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.